loadpatents
Patent applications and USPTO patent grants for Peluso; Stephane.The latest application filed is for "inhibitors of e1 activating enzymes".
Patent | Date |
---|---|
Cyclopamine analogs Grant 11,007,181 - Austad , et al. May 18, 2 | 2021-05-18 |
Inhibitors of E1 activating enzymes App 20210070798 - CRITCHLEY; Stephen ;   et al. | 2021-03-11 |
Cyclopamine Analogs App 20200121658 - Austad; Brian ;   et al. | 2020-04-23 |
Cyclopamine analogs Grant 10,406,139 - Austad , et al. Sept | 2019-09-10 |
Cyclopamine Analogs App 20190000816 - Austad; Brian ;   et al. | 2019-01-03 |
Cyclopamine analogs Grant 9,951,083 - Austad , et al. April 24, 2 | 2018-04-24 |
Substituted Pyrrolo[2,3-d]pyrimidines App 20180086785 - CRITCHLEY; Stephen ;   et al. | 2018-03-29 |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 9,718,788 - Claiborne , et al. August 1, 2 | 2017-08-01 |
Tetrazolones As Inhibitors Of Fatty Acid Synthase App 20170119734 - Bahadoor; Adilah ;   et al. | 2017-05-04 |
Inhibitors of monoacylglycerol lipase and methods of their use Grant 9,630,979 - Castro , et al. April 25, 2 | 2017-04-25 |
Substituted Pyrrolo[2,3-d]pyrimidines App 20170073367 - Critchley; Stephen ;   et al. | 2017-03-16 |
Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20170050935 - CLAIBORNE; Christopher F. ;   et al. | 2017-02-23 |
Cyclopamine Analogs App 20170022212 - Austad; Brian ;   et al. | 2017-01-26 |
Cyclopamine analogs Grant 9,492,435 - Austad , et al. November 15, 2 | 2016-11-15 |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 9,458,108 - Claiborne , et al. October 4, 2 | 2016-10-04 |
Substituted Pyrrolo[2,3-d]pyrimidines App 20160194348 - Critchley; Stephen ;   et al. | 2016-07-07 |
Tetrazolones as inhibitors of fatty acid synthase Grant 9,346,769 - Bahadoor , et al. May 24, 2 | 2016-05-24 |
Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20160039761 - CLAIBORNE; Christopher F. ;   et al. | 2016-02-11 |
Isoxazolines as inhibitors of fatty acid amide hydrolase Grant 9,149,465 - Behnke , et al. October 6, 2 | 2015-10-06 |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 9,150,525 - Claiborne , et al. October 6, 2 | 2015-10-06 |
Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20150183753 - Claiborne; Christopher F. ;   et al. | 2015-07-02 |
Isoxazolines As Inhibitors Of Fatty Acid Amide Hydrolase App 20150099738 - BEHNKE; Mark L. ;   et al. | 2015-04-09 |
Isoxazolines as inhibitors of fatty acid amide hydrolase Grant 8,927,551 - Behnke , et al. January 6, 2 | 2015-01-06 |
Cyclopamine Analogs App 20140371253 - Austad; Brian ;   et al. | 2014-12-18 |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 8,901,136 - Critchley , et al. December 2, 2 | 2014-12-02 |
Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20140303193 - Claiborne; Christopher F. ;   et al. | 2014-10-09 |
Substituted Pyrrolo]2,3-d]pyrimidines App 20140256668 - CRITCHLEY; Stephen ;   et al. | 2014-09-11 |
Cyclopamine analogs Grant 8,785,635 - Austad , et al. July 22, 2 | 2014-07-22 |
Isoxazolines as inhibitors of fatty acid amide hydrolase Grant 8,765,735 - Behnke , et al. July 1, 2 | 2014-07-01 |
Tetrazolones As Inhibitors Of Fatty Acid Synthase App 20140079667 - BAHADOOR; Adilah ;   et al. | 2014-03-20 |
Cyclopamine analogs Grant 8,669,365 - Austad , et al. March 11, 2 | 2014-03-11 |
Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20130345242 - Claiborne; Christopher F. ;   et al. | 2013-12-26 |
Substituted Pyrrolo]2,3-d]pyrimidines App 20130338094 - CRITCHLEY; Stephen ;   et al. | 2013-12-19 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,609,706 - Castro , et al. December 17, 2 | 2013-12-17 |
Tetrazolones as inhibitors of fatty acid synthase Grant 8,546,432 - Bahadoor , et al. October 1, 2 | 2013-10-01 |
Triazoles As Inhibitors Of Fatty Acid Synthase App 20130243727 - BAHADOOR; Adilah ;   et al. | 2013-09-19 |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 8,481,550 - Claiborne , et al. July 9, 2 | 2013-07-09 |
Triazoles as inhibitors of fatty acid synthase Grant 8,450,350 - Bahadoor , et al. May 28, 2 | 2013-05-28 |
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20130131063 - Castro; Alfredo C. ;   et al. | 2013-05-23 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,304,428 - Castro , et al. November 6, 2 | 2012-11-06 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,178,690 - Castro , et al. May 15, 2 | 2012-05-15 |
Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes App 20120071482 - Claiborne; Christopher F. ;   et al. | 2012-03-22 |
Tetrazolones As Inhibitors Of Fatty Acid Synthase App 20110274655 - BAHADOOR; Adilah ;   et al. | 2011-11-10 |
Triazoles As Inhibitors Of Fatty Acid Synthase App 20110274654 - BAHADOOR; Adilah ;   et al. | 2011-11-10 |
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20110213145 - Castro; Alfredo C. ;   et al. | 2011-09-01 |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes Grant 8,008,307 - Claiborne , et al. August 30, 2 | 2011-08-30 |
Inhibitors Of E1 Activating Enzymes App 20110136834 - Critchley; Stephen ;   et al. | 2011-06-09 |
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes Grant 7,951,810 - Critchley , et al. May 31, 2 | 2011-05-31 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 7,928,244 - Castro , et al. April 19, 2 | 2011-04-19 |
Isoxazolines As Inhibitors Of Fatty Acid Amide Hydrolase App 20110034437 - Behnke; Mark L. ;   et al. | 2011-02-10 |
Isoxazolines As Inhibitors Of Fatty Acid Amide Hydrolase App 20110028482 - Behnke; Mark L. ;   et al. | 2011-02-03 |
Isoxazolines As Inhibitors Of Fatty Acid Amide Hydrolase App 20110028478 - Behnke; Mark L. ;   et al. | 2011-02-03 |
Cyclopamine analogs Grant 7,812,164 - Austad , et al. October 12, 2 | 2010-10-12 |
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20100190791 - CASTRO; ALFREDO C. ;   et al. | 2010-07-29 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 7,745,464 - Castro , et al. June 29, 2 | 2010-06-29 |
Cyclopamine Analogs App 20090216022 - Austad; Brian ;   et al. | 2009-08-27 |
Cyclopamine Analogs App 20090012109 - Austad; Brian ;   et al. | 2009-01-08 |
Cyclopamine Analogs App 20080293754 - Austad; Brian ;   et al. | 2008-11-27 |
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20080114167 - CASTRO; Alfredo C. ;   et al. | 2008-05-15 |
Heteroaryl compounds useful as inhibitors of E1 activating enzymes App 20080051404 - Claiborne; Christopher F. ;   et al. | 2008-02-28 |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners App 20070155705 - Castro; Alfredo C. ;   et al. | 2007-07-05 |
Inhibitors of E1 activating enzymes App 20060189636 - Critchley; Stephen ;   et al. | 2006-08-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.